Literature DB >> 23625309

[Catheter ablation of persistent and long-standing persistent atrial fibrillation. Strategies and results].

Daniel Steven1, Arian Sultan, Benjamin Schäffer, Helge Servatius, Boris Hoffmann, Jakob Lüker, Stephan Willems.   

Abstract

Catheter ablation for paroxysmal atrial fibrillation is a meanwhile established therapy option, which is most frequently performed using radiofrequency ablation. Mid-term success rate of 70 % are achievable with a single ablation procedure. However, the mechanistics of persistent atrial fibrillation are less well understood and catheter ablation is a far more challenging procedure. Different ablation approaches are being performed to treat persistent atrial fibrillation ranging from sole pulmonary vein isolation to additional ablation of fractionated electrograms aiming for termination of atrial fibrillation. Thus far, it has not been investigated which strategy is most successful in treating persistent atrial fibrillation. After extended ablation of atrial fibrillation, occurrence of organized atrial arrhythmias is not uncommon and can be successfully ablated. These consecutive arrhythmias can be considered as a next step towards stable sinus rhythm after repeat ablation. Improvement of mapping methods as well as a better understanding of mechanisms of atrial fibrillation may increase success rate of catheter ablation of persistent atrial fibrillation and may also help to improve success rate of these complex procedures.

Entities:  

Mesh:

Year:  2013        PMID: 23625309     DOI: 10.1007/s00399-013-0245-y

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  16 in total

1.  Persistence of pulmonary vein isolation after robotic remote-navigated ablation for atrial fibrillation and its relation to clinical outcome.

Authors:  Stephan Willems; Daniel Steven; Helge Servatius; Boris A Hoffmann; Imke Drewitz; Kai Müllerleile; Muhammet Ali Aydin; Karl Wegscheider; Tushar V Salukhe; Thomas Meinertz; Thomas Rostock
Journal:  J Cardiovasc Electrophysiol       Date:  2010-10

2.  Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.

Authors:  Michel Haïssaguerre; Mélèze Hocini; Prashanthan Sanders; Frederic Sacher; Martin Rotter; Yoshihide Takahashi; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

3.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

4.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.

Authors:  Sanjiv M Narayan; David E Krummen; Kalyanam Shivkumar; Paul Clopton; Wouter-Jan Rappel; John M Miller
Journal:  J Am Coll Cardiol       Date:  2012-07-18       Impact factor: 24.094

5.  Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence.

Authors:  Gerhard Hindricks; Christopher Piorkowski; Hildegard Tanner; Richard Kobza; Jin-Hong Gerds-Li; Corrado Carbucicchio; Hans Kottkamp
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

6.  Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.

Authors:  Jin-Seok Kim; Fei She; Krit Jongnarangsin; Aman Chugh; Rakesh Latchamsetty; Hamid Ghanbari; Thomas Crawford; Arisara Suwanagool; Mohammed Sinno; Thomas Carrigan; Robert Kennedy; Wouter Saint-Phard; Miki Yokokawa; Eric Good; Frank Bogun; Frank Pelosi; Fred Morady; Hakan Oral
Journal:  Heart Rhythm       Date:  2012-12-11       Impact factor: 6.343

Review 7.  Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review.

Authors:  Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders
Journal:  Heart Rhythm       Date:  2010-01-22       Impact factor: 6.343

8.  Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?

Authors:  Rukshen Weerasooriya; Paul Khairy; Jean Litalien; Laurent Macle; Meleze Hocini; Frederic Sacher; Nicolas Lellouche; Sebastien Knecht; Matthew Wright; Isabelle Nault; Shinsuke Miyazaki; Christophe Scavee; Jacques Clementy; Michel Haissaguerre; Pierre Jais
Journal:  J Am Coll Cardiol       Date:  2011-01-11       Impact factor: 24.094

9.  Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation.

Authors:  Sander Verheule; Els Tuyls; Arne van Hunnik; Marion Kuiper; Ulrich Schotten; Maurits Allessie
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-10-11

10.  Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Rodney Horton; G Joseph Gallinghouse; Dhanunjay Lakkireddy; Atul Verma; Yaariv Khaykin; Richard Hongo; Steven Hao; Salwa Beheiry; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; Pasquale Santangeli; Paul Wang; Amin Al-Ahmad; Dimpi Patel; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Jennifer E Cummings; Robert A Schweikert; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-06-01       Impact factor: 29.690

View more
  1 in total

1.  The incidence, indications and predictors of acute pacemaker implantation after ablation of persistent atrial fibrillation.

Authors:  Verena Semmler; Felix von Krogh; Bernhard Haller; Tilko Reents; Felix Bourier; Marta Telishevska; Marc Kottmaier; Marielouise Kornmayer; Stephanie Brooks; Katharina Koch-Büttner; Carsten Lennerz; Amir Brkic; Christian Grebmer; Patrick Blazek; Severin Weigand; Gabriele Hessling; Christof Kolb; Isabel Deisenhofer
Journal:  Clin Res Cardiol       Date:  2018-11-20       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.